financetom
Business
financetom
/
Business
/
Update: Texas Instruments Shares Down Pre-Bell After Q2 Results, Q3 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Texas Instruments Shares Down Pre-Bell After Q2 Results, Q3 Guidance
Jul 23, 2025 3:07 AM

05:37 AM EDT, 07/23/2025 (MT Newswires) -- Texas Instruments ( TXN ) shares were down nearly 12% in recent premarket activity Wednesday after the company reported its Q2 results and issued a Q3 guidance overnight.

The company posted Q2 earnings late Tuesday of $1.41 per diluted share, up from $1.22 a year earlier.

Analysts polled by FactSet expected $1.36.

Revenue for the quarter ended June 30 was $4.45 billion, up from $3.82 billion a year earlier.

Analysts surveyed by FactSet expected $4.36 billion.

The company set Q3 EPS guidance of $1.36 to $1.60 on revenue of $4.45 billion to $4.80 billion. Analysts expected EPS of $1.51 on revenue of $4.59 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Akero Therapeutics To Be Acquired By Novo Nordisk For Up To $5.2 Billion
BRIEF-Akero Therapeutics To Be Acquired By Novo Nordisk For Up To $5.2 Billion
Oct 9, 2025
Oct 9 (Reuters) - Akero Therapeutics Inc ( AKRO ): * AKERO THERAPEUTICS TO BE ACQUIRED BY NOVO NORDISK FOR UP TO $5.2 BILLION * AKERO THERAPEUTICS INC ( AKRO ) - SHAREHOLDERS TO RECEIVE $54 PER SHARE IN CASH * AKERO THERAPEUTICS INC ( AKRO ) - SHAREHOLDERS TO RECEIVE $54 PER SHARE IN CASH AND CVR OF $6...
Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion
Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion
Oct 9, 2025
STOCKHOLM (Reuters) -Novo Nordisk said on Thursday it had agreed to buy Akero Therapeutics ( AKRO ) for up to $5.2 billion, giving the Danish drugmaker access to the U.S.-based company's experimental liver disease drug. The maker of blockbuster obesity drug Wegovy is pressing ahead with a sweeping restructuring in a bid to revive sales growth and fend off intense...
Netflix Adds Party Games to TV Service
Netflix Adds Party Games to TV Service
Oct 9, 2025
06:16 AM EDT, 10/09/2025 (MT Newswires) -- Netflix ( NFLX ) said Wednesday it will add TV party games to its platform for the holiday season, including Lego, Tetris and Pictionary themed offerings. Users will play the games through the Netflix TV app with a smartphone as their controller, the company said. ...
AZZ Fiscal Second-Quarter Results Miss Street Views
AZZ Fiscal Second-Quarter Results Miss Street Views
Oct 9, 2025
06:16 AM EDT, 10/09/2025 (MT Newswires) -- AZZ (AZZ) shares fell early Thursday as the metal and coil coatings company's fiscal second-quarter results came in short of market estimates, while it maintained its full-year outlook. The company reported adjusted earnings of $1.55 per share for the quarter ended August, up from $1.37 the year before, it said late Wednesday. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved